Toremifene citrateProduct Name: Toremifene citrate;FarestonCAS No.: 89778-27-8M.F.: C32H36ClNO8M.W.: 598.08Packing: 1kg/foil bagAssay: 99%Melting Point: 158-164℃Appearance: White powderMolecular Formula: C26H28ClNO· C6H8O7 Molecular Weight: 598.09 Molecular Structure: Melting Point: 158-164 º C Boiling Point: 535.1 º C at 760 mmHg Density: 1.045g/cm3 Refractive index: 1, 416-1, 418 Payment Method: Money Gram/Western Union T/T , Bitcoin .Product description:Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene citrate is FDA-approved for use in advanced (metastatic) breast cancer. It is also being evaluated for prevention of prostate cancer under the brand name Acapodene.In 2007 the pharmaceutical company GTx, Inc was conducting two different phase 3 clinical trials; First, a pivotal Phase clinical trial for the treatment of serious side effects of androgen deprivation therapy (ADT) (especially vertebral/spine fractures and hot flashes, lipid profile, and gynecomastia) for advanced prostate cancer, and second, a pivotal Phase III clinical trial for the prevention of prostate cancer in high risk men with high grade prostatic intraepithelial neoplasia, or PIN. Results of these trials are expected by first quarter of 2008Applications:Usually dosed around 60 mgs, some dose it up to 240 mgs. Its androgenicity:estrogenicity ratio is 5x that of Nolvadex. It is prescribed to female patients for breast cancer and has shown a high affinity for bonding to the Estrogen receptors in the breast tissue. Male patients treated with toremifene citrate 80 mg compared to placebo demonstrated statistically significant increases in bone mineral density in the lumbar spine, hip, and femur skeletal sites. It decreased the risk by up to 50%. Toremifene citrate 80 mg treatment compared to placebo also resulted in a decrease in total cholesterol, LDL, and triglycerides, and an increase in HDL. There were also statistically significant improvements in gynecomastia. This data are from an ongoing study of men receiving treatment for ADT (androgen depravation therapy). These men are receiving ADT for advanced prostate cancer. ADT removes much of the testosterone and estrogen in the body which helps the prostatic cancer cells grow. So these men were suffering from side effects from reduced estrogen and testosterone in the body. Some studies have even suggested that Torm doesn't regulate progesterone receptors and we may see in the future the possibility of using it with 19-nors. Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene citrate is FDA-approved for use in advanced (metastatic) breast cancer. It is also being evaluated for prevention of prostate cancer under the brand name Acapodene. It has already been covered that Toremifene is a SERM, and serves to block Estrogen at various receptor sites in certain tissues within the body (breast tissue in particular). As a layman explanation, Toremifene pretends to be a 'fake' Estrogen that occupies Estrogen receptors within breast tissue. With these receptors occupied by Toremifene, real Estrogen cannot perform their jobs there. Toremifene does not reduce total blood plasma levels of Estrogen. In addition to being antagonistic to Estrogen receptors in breast tissue, it is also antagonistic to Estrogen at the hypothalamus gland (this essentially 'tricks' the hypothalamus into thinking there is little or no circulating Estrogen levels in the body, causing it to increase its manufacture of Testosterone so that it can utilize aromatization to restore these levels.
Trenbolone (Steroids) Chemical Name: BETA-TRENBOLONE;17BETA-HYDROXYESTRA-4,9,11-TRIEN-3-ONE;17-HYDROXYESTRA-4,9,11-TRIEN-3-ONE;4,9,11-ESTRATRIEN-17-BETA-OL-3-ONE;TRENBOLONE;11-trien-3-one,17-beta-hydr
help
Add to favorite
Favorite products
![Tricyclo[3.3.1.13,7]decane-1-carboxylicacid (Tricyclo[3.3.1.13,7]decane-1-carboxylicacid)](http://www.asia.ru/upload_images/icons/163/162512/1881685.jpg){kind=icon}
